RCP
TEVA icon

Radin Capital Partners’s Teva Pharmaceuticals TEVA Stock Holding History

Radin Capital Partners’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$3.09M Hold
449,200
– – 10.55% 5
2019
Q2 		$4.15M Hold
449,200
– – 8.1% 9
2019
Q1 		$7.04M Hold
449,200
– – 8.65% 6
2018
Q4 		$6.93M Hold
449,200
– – 8.4% 8
2018
Q3 		$9.68M Buy
+449,200
New +$10.4M 9.02% 7

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

Radin Capital Partners's TEVA Position: Q3 2019 in Review

Radin Capital Partners held its Teva Pharmaceuticals (TEVA) position steady in Q3 2019 at 449,200 shares worth $3.09M. The position accounts for 10.55% of the portfolio, ranked #5.

Radin Capital Partners first reported a position in TEVA in Q3 2018 and has held it in 5 quarters since. The position peaked at $9.68M in Q3 2018. 428 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • Radin Capital Partners held 449,200 shares of Teva Pharmaceuticals worth $3.09M as of Q3 2019.
  • Radin Capital Partners left its Teva Pharmaceuticals share count unchanged in Q3 2019.
  • Teva Pharmaceuticals made up 10.55% of Radin Capital Partners's portfolio in Q3 2019, its #5 holding.
  • Radin Capital Partners first reported a position in Teva Pharmaceuticals in Q3 2018 and has held it in 5 quarters since.
  • Radin Capital Partners's Teva Pharmaceuticals position peaked at $9.68M in Q3 2018.
  • 428 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on Radin Capital Partners's 13F filing for Q3 2019, filed 23 Oct 2019.